Encompass Health (US.EHC)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.EHC · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 48.1% | ↑ |
| ROE | 7.7% | ↑ |
| Cash Conversion | 161.0% | ↓ |
| D/E Ratio | 1.11 | ↑ |
| Gross Margin | 95.9% | → |
US.EHC (Encompass Health) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY ---------------------------- FCF Conversion 48.1% ↑ ROE 7.7% ↑ Cash Conversion 161.0% ↓ D/E Ratio 1.11 ↑ Gross Margin 95.9% →
Key Metrics
US.EHC (Encompass Health) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY----------------------------FCF Conversion 48.1% ↑ROE 7.7% ↑Cash Conversion 161.0% ↓D/E Ratio 1.11 ↑Gross Margin 95.9% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies